These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6328700)

  • 1. Opiate antagonists in the treatment of stroke.
    Faden AI
    Stroke; 1984; 15(3):575-8. PubMed ID: 6328700
    [No Abstract]   [Full Text] [Related]  

  • 2. Opiate antagonists and thyrotropin-releasing hormone. I. Potential role in the treatment of shock.
    Faden AI
    JAMA; 1984 Sep; 252(9):1177-80. PubMed ID: 6088820
    [No Abstract]   [Full Text] [Related]  

  • 3. New pharmacologic approaches to spinal cord injury: opiate antagonists and thyrotropin-releasing hormone.
    Faden AI
    Cent Nerv Syst Trauma; 1985; 2(1):5-8. PubMed ID: 3004747
    [No Abstract]   [Full Text] [Related]  

  • 4. [Opiate receptors, endorphins and their antagonists].
    Papin AA; Karelin AA
    Anesteziol Reanimatol; 1984; (3):52-61. PubMed ID: 6148029
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of thyrotropin-releasing hormone and opiate receptor antagonists in limiting central nervous system injury.
    Faden AI
    Adv Neurol; 1988; 47():531-46. PubMed ID: 2830771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone and mortality in the gerbil stroke model.
    Benzel EC; Musgrove CC; Kesterson L
    South Med J; 1989 May; 82(5):555-7. PubMed ID: 2717980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the specificity of naloxone as an opiate antagonist.
    Sawynok J; Pinsky C; LaBella FS
    Life Sci; 1979 Nov; 25(19):1621-32. PubMed ID: 229377
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone.
    Hosobuchi Y; Baskin DS; Woo SK
    Science; 1982 Jan; 215(4528):69-71. PubMed ID: 6274019
    [No Abstract]   [Full Text] [Related]  

  • 9. Naloxone in endotoxic shock: experimental models and clinical perspective.
    Gurll N
    Adv Shock Res; 1983; 10():63-71. PubMed ID: 6308974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auricular acupuncture in animals: effects of opiate withdrawal and involvement of endorphins.
    Ng LK
    J Altern Complement Med; 1996; 2(1):61-3; discussion 73-5. PubMed ID: 9395644
    [No Abstract]   [Full Text] [Related]  

  • 11. Opiate antagonists in experimental stroke.
    Iacono RP; Sandyk RR
    J Neurosurg; 1986 Sep; 65(3):425-7. PubMed ID: 3734897
    [No Abstract]   [Full Text] [Related]  

  • 12. Endorphins in shock and spinal injury; therapeutic effects of naloxone and thyrotropin-releasing hormone.
    Holaday JW
    Prog Clin Biol Res; 1983; 111():167-84. PubMed ID: 6306678
    [No Abstract]   [Full Text] [Related]  

  • 13. Stereospecific effects of opiate antagonists on superficial and deep nociception and on motor activity suggest involvement of endorphins on different opioid receptors.
    Ramabadran K; Jacob JJ
    Life Sci; 1979 May; 24(21):1959-69. PubMed ID: 222987
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular consequences of endogenous opiate antagonism.
    Holaday JW
    Biochem Pharmacol; 1983 Feb; 32(4):573-85. PubMed ID: 6299300
    [No Abstract]   [Full Text] [Related]  

  • 15. [Opiate hypothesis of the origin of early childhood autism and sequelae for psychopharmacotherapy].
    Lensing P; Klingler D; Panksepp J; Huber M; Saria A; Hackenberg B; Adam H
    Z Kinder Jugendpsychiatr; 1992 Sep; 20(3):185-96. PubMed ID: 1329399
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of narcotics and narcotic antagonists on affective disorders, schizophrenia and serum neurohormones.
    Judd LL; Janowsky DS
    Mod Probl Pharmacopsychiatry; 1981; 17():213-25. PubMed ID: 6120452
    [No Abstract]   [Full Text] [Related]  

  • 17. Opiate receptors and endorphins in the pathophysiology of hemorrhagic shock.
    Gurll NJ; Vargish T; Reynolds DG; Lechner RB
    Surgery; 1981 Mar; 89(3):364-9. PubMed ID: 6258256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular effects of opioid receptor blocker naloxone].
    Osadchiĭ OE; Pokrovskiĭ VM
    Eksp Klin Farmakol; 2001; 64(3):72-5. PubMed ID: 11558446
    [No Abstract]   [Full Text] [Related]  

  • 19. [New perspectives in the treatment of shock. Use of naloxone].
    González-Esparza L
    Rev Med Univ Navarra; 1982 Mar; 26(1):55-8. PubMed ID: 7111954
    [No Abstract]   [Full Text] [Related]  

  • 20. [Endorphins, enkephalins and their antagonists in clinical practice (review of the literature)].
    Oleĭnik VA; Khalangot ND
    Vrach Delo; 1985 May; (5):80-6. PubMed ID: 2990108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.